LINDY KNIGHT: Open Payments
NPI 1447617337 · WHEELING, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 25 payments from 8 companies in 2025. Trend: 2023 $353 · 2024 $572 · 2025 $535
Food & beverage: $435Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $199 |
| Novartis Pharmaceuticals Corporation | 8 | $148 |
| GENZYME CORPORATION | 3 | $67 |
| UCB, Inc. | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Amgen Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: TREMFYA, COSENTYX, DUPIXENT, Bimzelx, NEMLUVIO, OTEZLA, AXERT, SKYRIZI.
Industry payments across WV — which companies pay providers there.
